SAN FRANCISCO, CA USA (UroToday.com) - Presented by Steven E. Finkelstein, Luke T. Nordquist, Shaker R. Dakhil, Nathan B. Green, Elisabeth I. Heath, Ronald Tutrone, Nicholas J. Vogelzang, Andrew J. Armstrong, Matthew R. Cooperberg, Robert Claude Tyler, Robert Brownell Sims, James Boyd Whitmore, and Celestia S. Higano at the 2014 Genitourinary Cancers Symposium - January 30 - February 1, 2014 - San Francisco Marriott Marquis - San Francisco, California USA
FREE DAILY AND WEEKLY NEWSLETTERS OFFERED BY CONTENT OF INTEREST
Did you find this article relevant? Subscribe to UroToday-GUOncToday!
The fields of GU Oncology and Urology are advancing rapidly including new treatments, enrolling clinical trials, screening and surveillance recommendations along with updated guidelines. Join us as one of our subscribers who rely on UroToday as their must-read source for the latest news and data on drugs. Sign up today for blogs, video conversations, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.
21st Century Oncology, Translational Research Consortium, Scottsdale, AZ; Oncology Hematology West PC, Omaha, NE; Cancer Center of Kansas, Wichita, KS; Southeast Nebraska Hem and Onc Consult PC, Lincoln, NE; Karmanos Cancer Institute/Wayne State University, Detroit, MI; Chesapeake Urologic Research Associates, Baltimore, MD; Comprehensive Cancer Centers of Nevada, Las Vegas, NV; Duke University, Durham, NC; University of California, San Francisco, San Francisco, CA; Dendreon Corporation, Seattle, WA; University of Washington/Seattle Cancer Care Alliance, Seattle, WA